ACE and ovarian cancer: A number of large cohort studies on the association between the antihypertensive medication use and ovarian cancer death risk showed a significant beneficial effect of post-diagnostic angiotensin-converting enzyme inhibitors (ACE inhibitors) use on cancer-specific survival compared to not users [6, 7].